The FGFR inhibitor pemigatinib overcomes cancer drug resistance to KRAS G12C inhibitors in mesenchymal lung cancer - Angela Abdollahi; Margaret Favata; Michael Weber; Valerie Roman; Rodrigo Hess; Kayla Hammond; Matthew R. Farren; Mike Schaffer; Aidan Gilmartin; Hui Wang; Jonathan Rios-Doria; Alejandro Amador-Arjona (PLoS ONE, 2025)